Chii chaitika
Mithrl, kambani yeSan Francisco-based AI infrastructure, yakazivisa mamiriyoni makumi maviri emadhora Series A mari yekutenderera inotungamirwa neObvious Ventures, nekutora chikamu kubva kuMusoro, AGI House, uye akati wandei vatariri vemishonga. Iyo kambani, yakavambwa muna 2023 naVivek Adarsh naShara Balakrishnan, inogadzira 'Scientific Decision Engine' (Mithrl-1) inoshanda semuenzaniso wepasi rose. Kusiyana nemhando dzekugadzira dzinogadzira kutevedzana kwemamorekuru, puratifomu yaMithrl inoburitsa hukama hwakasimbiswa kubva kumabhuku akaongororwa nevezera uye dhatabheti dzeshamwari kuzivisa sarudzo dzeR&D pane yese yekuwana zvinodhaka. Mari iyi ichatsigira kukura kwechikwata chayo chevanhu makumi matatu uye kuwedzera munzvimbo dzekurapa dzinosanganisira oncology, chirwere chekudzivirira muviri, uye chirwere chemetabolism. Mithrl akazivisawo kuti kuwana kwekutanga kune yayo yechipiri-chizvarwa chikuva kuchavhura svondo rinouya.
Mithrl akazivisa $20 miriyoni Series A mari yekutenderera inotungamirwa neObvious Ventures, nekuwedzera kutora chikamu kubva Headline, AGI House, uye pharma vatariri. Izvi zvinotevera kutenderera kwembeu yemamiriyoni mana emadhora inotungamirwa neBonfire Ventures muna Mbudzi 2024. Kambani iyi iri muSan Francisco uye yakavambwa muna 2023 naVivek Adarsh, aimbove NVIDIA uye HP Labs injiniya, naShara Balakrishnan.
Chigadzirwa chikuru chekambani, Mithrl-1, chinotsanangurwa se 'Sainzi Yechisarudzo Injini' kwete yebiology hwaro modhi. Iyo haiburitse mamorekuru matsva kana kutevedzana kweantibody asi pachinzvimbo inoshandisa iyo biomedical yenyika modhi yakasvibiswa kubva kune vezera-yakaongororwa mabhuku uye veruzhinji/vanodyidzana dataset. Iyi modhi inobata hukama hwakasimbiswa pakati pemajini, nzira, uye zvirwere kuzivisa R&D sarudzo kubva pakuzivikanwa kwechinangwa kuenda kunhare dzekushandura.
Iyi puratifomu inoshanda seagentic harness inobata modhi nzira, optimization, uye mamiriro ekuimba. Iyo inotumirwa kumberi mukati mevatengi vega nharaunda, ichivabvumira kuti vashandise vavanoda mamodheru mamodheru uye kuwedzera chikuva nedata revaridzi. Mithrl anoti hurongwa hwayo hunoshandisa 45% mashoma ma tokens pane akajairwa mafambiro uye anowana 0.96 mamakisi echokwadi chesainzi mumabhenji akayerwa nenyanzvi, zvichienzaniswa ne0.60 isina chikuva.
Mithrl's user base inosanganisira epamusoro-gumi makambani emishonga, kiriniki-nhanho biotechs, uye genomics papuratifomu vanobatana. Kudyidzana kunoshamisa neElephas Biosciences, yakaziviswa muna Kubvumbi, vaviri-chaiyo-nguva ex vivo bundu profiling neAI-inotungamirwa ongororo yekuona immunotherapy mhinduro masaini. Iyo kambani inotaura kuti zvakawanikwa kuburikidza nepuratifomu yayo zvakabatsira kune inodarika hafu yegumi nevaviri yevatengi-vane patent mafaira.
Mari iyi nyowani ichashandiswa kuwedzera kambani yevanhu vangangosvika makumi matatu uye kuwedzera kutarisisa kwayo munzvimbo dzekurapa dzakadai sechirwere chekudzivirira muviri, oncology, chirwere cheshuga, chirwere chemetabolism, uye chirwere chemoyo. Mithrl akazivisawo kuti kuwana kwekutanga kupuratifomu yechizvarwa chechipiri kuchavhura svondo rinouya, kunyangwe mitengo chaiyo uye ruzivo rwekuwanikwa kwakawanda hazvina kupihwa mune sosi.
Kwakabva mashoko: en.wowtale.net ↗
Nei zvichikosha
Iyi mari inoratidzira shanduko muAI-inotyairwa biopharma kubva kuchizvarwa chekufungidzira kuenda kune hypothesis kusimbiswa uye triage. Nepo AI ichikwanisa kukurumidza kuburitsa zvibodzwa zvevamiriri, iyo bhodhoro inoramba ichitarisa kuti ndeapi mafungidziro akabatika mumalabhu akanyorova uye nekiriniki marongero. Mithrl's infrastructure approach, iyo inobatanidza nearipo emuganho mamodheru uye proprietary client data, inogadzirisa gaka iri nekupa chivimbo-chakapihwa, humbowo-hwakateedzerwa kurudziro. Iyi modhi inoderedza njodzi yekutevera nhanho dzisina kusimba, zvichigona kumhanyisa nzira kubva pane zano kuenda kuIND yekuisa. Iko kudyara kunoratidza chivimbo chemusimasi mune yakasarudzika, domain-yakavakirwa AI zvivakwa pamusoro pese-chinangwa chesainzi vamiririri.
Iyo AI yekuwanikwa kwezvinodhaka chikamu yakakwezva inodarika mabhiriyoni gumi nerimwe emadhora mubhizimusi rekutanga gore rapfuura, asi gaka rakakura richiripo pakati pekugadzira fungidziro nekudzisimbisa mumalabhu akanyorova. Mithrl's infrastructure inogadzirisa izvi nekupa triage layer iyo inokonzeresa mukati meiyo yakasimbiswa biology, ichidzikisa njodzi yekutevera isingaite inotungamira uye nekugona kumhanyisa nzira kubva kune zano kuenda kuIND faira.
Nekuzvimisikidza sechigadziro chezvivakwa kwete chemorekuru-dhizaini, Mithrl anozvisiyanisa kubva kumakambani akaita seXaira Therapeutics uye Isomorphic Labs. Maitiro ayo anobvumira zvikwata zvebiopharma kuchengetedza kutonga pamusoro pe data uye sarudzo dzemhando, kudzivirira kuvharika kwevatengesi uku vachisimudzira masimba emamodheru aripo.
Kudyara kunoratidza maitiro akakura muAI-ye-biology yakanangana nehunyanzvi, domain-yakavakirwa masisitimu anobatana nearipo mafambiro ebasa. Vagadziri vemari vakaita seObvious Ventures vanosimbisa kuti mukana wakasimba uri mu data revaridzi, mhando dzepasirese, uye tsika masisitimu akarongedzerwa kune chaiwo biopharma zvinodiwa, pane imwe saizi-inokodzera-ese mhinduro.
Mithrl akati mametrics ekuita, anosanganisira kurongeka kwepamusoro kwesainzi uye kuderedzwa kwekushandisa tokeni, zvinokurudzira zvingangoitika zvekubudirira kwezvikwata zveR&D. Nekudaro, izvi mhedzisiro zvinoenderana nekambani yayo mabhenji uye nyanzvi-yakatemerwa ongororo, uye yakazvimiririra yekuongorora munzvimbo dzakasiyana-siyana dzepasirese ichiri kumirira.
Interactive Mechanism: Iyo Inonyatsoshanda
Ongorora ari pasi tekinoroji kuseri kwekusimudzira uku uchipindirana.
crm_get_transaction(id='4092').An agent must create a draft calendar event for Tuesday at 2 p.m. Which evidence would establish the requested result?
Zvekutarisa zvinotevera
Tarisa kuburitswa kwechikuva chechipiri cheMithrl uye chirongwa chayo chekutanga chekuwana. Tarisa kune kumwe kudyidzana nemakambani gumi epamusoro emishonga uye zvekiriniki-nhanho biotechs. Tarisa uone kana izvo zvinonzi zvinobudirira zvakawanikwa, senge 45% mashoma tokens uye yepamusoro yesainzi zvibodzwa, zvinosimbiswa zvakazvimirira mukutumirwa kwepasirese. Tarisa uone kuti Mithrl anozvisiyanisa sei kubva kune vakwikwidzi vakaita seArgon AI uye general-chinangwa vanotsvagisa vamiririri munzvimbo yakazara AI-ye-biology.
Kutangwa kwepuratifomu yechizvarwa chechipiri cheMithrl uye zvirevo zvechirongwa chayo chekutanga chekuwana zvichave zviratidzo zvakakosha zvekutengesa kwayo uye kuvandudzwa kwehunyanzvi. Tsanangudzo chaiyo pamitengo, mamiriro ekuwana, uye zvinodiwa zvekubatanidzwa hazvizivikanwe parizvino.
Kumwezve kudyidzana nemakambani makuru eparma uye mabiotechs acharatidza scalability yepuratifomu uye kutorwa munzvimbo dzakakwirira dzeR&D. Kuwedzera munzvimbo nyowani dzekurapa kuchayedza kusarudzika kwepuratifomu uye kudzika kweruzivo rwesizinda.
Kuzvimiririra kusimbiswa kwezvichemo zvekuita kwaMithrl, senge 45% kuderedzwa kwetokeni uye 0.96 yesainzi yechokwadi mamakisi, ichave yakakosha pakumisa kuvimbika munharaunda yesainzi. Mabhuku akatariswa nevezera kana ongororo yebato rechitatu anogona kupa kusimbiswa uku.
Makwikwi emagetsi nevamwe vatambi veAI zvivakwa, seArgon AI uye general-chinangwa vamiririri vekutsvagisa, vanogadzira mamiriro emusika. Kugona kwaMithrl kuchengetedza muganhu wayo mu-domain-chaiyo chaiyo uye kusanganisa kuchinjika kuchava chinhu chakakosha mukubudirira kwayo kwenguva refu.